A platform of Innovation Platform Capital

Critical health products &
manufacturing
infrastructure.

iPC GenZen Pharmaceuticals originates, develops, and operates regulated pharmaceutical product portfolio & manufacturing infrastructure at institutional scale. We are the sponsor of essential medicines for the next generation of healthcare supply chains.

300+Products developed and approved across international markets
$200M+Targeted GMP infrastructure capex per facility
25 YEARSAsset operating horizon per facility
4Regulated pathways: FDA, EMA, WHO-PQ, CDSCO
Who we are

Not a drug company. The infrastructure sponsor
behind essential medicines.

iPC GenZen Pharmaceuticals is the Healthcare platform of Innovation Platform Capital. We operate at the intersection of pharmaceutical science and infrastructure sponsorship — originating, financing, building, and operating GMP manufacturing facilities for essential medicines, complex generics, and specialty products at institutional scale.

We partner with industry leaders across the globe to license, co-develop or develop therapies that expand access, reduce cost, and improve patient outcomes. We do not trade pills — we sponsor the infrastructure that produces them for 25 years.

PLATFORM AREAS

Four disciplines. One manufacturing sponsor.

Investment highlights

A capital-efficient platform built for durable advantage.

01

Specialized Expertise

Deep focus on complex generics and 505(b)(2) NDAs, areas with high regulatory barriers and limited competition.

02

Prior Experience

Over 300 products developed and approved across major international markets.

03

Scalable Model

Capital-efficient, partnership-driven structure focused on risk mitigation and speed to market.

04

Global Vision

Strong pipeline and strategic partnerships supporting expansion into new categories and geographies.

05

Mission-Driven

Committed to improving patient access to effective, affordable therapies through science and collaboration.

Part of the IPC ecosystem

Institutional backing. Entrepreneurial speed.

iPC GenZen is the Healthcare platform of Innovation Platform Capital, a strategic critical healthcare firm. iPC provides the governance, capital discipline, and platform infrastructure; iPC GenZen brings deep pharmaceutical development, regulatory expertise, and manufacturing execution. Capital consolidates into a Luxembourg SCSp, then deploys at the platform level under one operating discipline.

Innovation Platform CapitalGenZen Pharmaceuticals
IPC Group
Full-lifecycle infrastructure sponsor. Originate, structure, capitalise, scale. Luxembourg SCSp. Four active platforms across Energy, Digital, Healthcare, and Industrial.
GenZen Portfolio Company
Healthcare platform. GMP manufacturing infrastructure, complex pharmaceutical development, regulatory execution, and long-term operating management.

A proven, visionary partner ready to deliver.

Whether you're seeking a reliable development partner, a pathway into regulated markets, or a scalable investment in the future of pharmaceuticals.